None

Gilteritinib's efficacy and impact on a patient's lifespan will vary depending on individual differences, disease stage, the patient's overall health, and whether combination therapy is used. Giritinib is commonly used to treat FLT3 mutation-positive acute myeloid leukemia (AML), a complex subtype of leukemia.

The duration and effectiveness of treatment vary depending on the individual patient's condition. Some patients may achieve complete remission after treatment with giritinib and be able to control their disease long-term and extend their survival. However, for other patients, the response may be shorter, or other treatments may need to be tried if the disease relapses.

Giritinib is commonly used as first-line treatment or as a treatment option for relapsedAML, especially in patients who are FLT3 mutation-positive. In some clinical studies, giritinib has shown the potential to improve survival and response rates. However, long-term survival and disease control often also depend on multiple factors, including the patient's genetic characteristics, treatment response, treatment tolerance, and continued monitoring of follow-up.

Giritinib is currently on the market in China, but it is not included in medical insurance. If patients need it, they can go to the hospital to buy it at their own expense, but the price is very high, about about 35,000 yuan. For specific prices, please consult the local hospital pharmacy. Foreign original drugs of gilitinib are even more expensive. For example, the price of the Hong Kong version of the original drug is around 90,000 yuan, and the European version of the original drug is as high as more than 200,000 yuan, which is simply unaffordable for ordinary patients. But what is gratifying is that there are already foreign generic drugs of giritinib, mainly Laotian generic drugs. The price is about four to five thousand yuan, which is relatively cheap. In terms of drug ingredients, the ingredients of domestic and foreign original gilitinib drugs are basically the same as those of generic drugs.